Drug Approval | July 05, 2023
Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Subscribe To Our Newsletter & Stay Updated
